Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 3, 2013, Pages 429-435

  Ji, Hong Fei ^a   Pang, Da ^a   Fu, Song Bin ^a   Jin, Yan ^a   Yao, Lei ^a   Qi, Ji Ping ^b   Bai, Jing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Focal adhesion kinase; Metastasis; Non small cell lung carcinoma; Prognosis

Indexed keywords

FOCAL ADHESION KINASE; MESSENGER RNA; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; ADENOCARCINOMA; EVALUATION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; LYMPH NODE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

MLCS; MLOWN;

EID: 84876343011     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1342-8     Document Type: Article

References (34)

1. Benlimame N, He Q, Jie S et al (2005) FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol 171:505-516
2. Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of prognosis. Chest 122:1037-1057
3. Carelli S, Zadra G, Vaira V, et al (2006) Up-regulation of focal adhesion kinase in non-small cell lung cancer. Lung Cancer. 53(3):263-71
4. Dunn KB, Heffler M, Golubovskaya VM (2010) Evolving therapies and FAK inhibitors for the treatment of cancer. Anticancer Agents Med Chem 10:722-734
5. Evan G (2010) Getting one's Fak straight. Dev Cell 19:185-186
6. Frame MC, Patel H, Serrels B et al (2010) The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol 11:802-814
7. Garces CA et al (2006) Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res 66:1446-1454
8. Golubovskaya VM, Conway-Dorsey K, Edmiston SN et al (2009a) FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer 125:1735-1738
9. Golubovskaya VM, Kweh FA, Cance WG (2009b) Focal adhesion kinase and cancer. Histol Histopathol 24:503-510
10. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674
11. Hirsch FR, Spreafico A, Novello S et al (2008) The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 3:1468-1481
12. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics 2010. CA Cancer J Clin 60:277-300
13. Kurio N, Shimo T, Fukazawa T et al (2011) Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. Exp Cell Res 317:1134-1146
14. Lesslie DP, Summy JM, Parikh NU et al (2006) Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer 94:1710-1717
15. Ma WW (2011) Development of focal adhesion kinase inhibitors in cancer therapy. Anticancer Agents Med Chem 11:638-642
16. McLean GW, Carragher NO, Avizienyte E et al (2005) The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5:505-515
17. Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449-458
18. Meng XN, Jin Y, Yu Y et al (2009) Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 101:327-334
19. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6:56-68
20. Ocak S, Yamashita H, Udyavar AR et al (2010) DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene 29:6331-6342
21. Ocak S, Chen H, Callison C et al (2012) Expression of focal adhesion kinase in small-cell lung carcinoma. Cancer 118:1293-1301
22. Paez JG, Janne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497-1500
23. Provenzano PP, Keely PJ (2009) The role of focal adhesion kinase in tumor initiation and progression. Cell Adh Migr 3:347-350
24. Roberts WG, Ung E, Whalen P et al (2008) Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 68:1935-1944
25. Sandler A, Gray R, Perry MC et al (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542-2550
26. Schwock J, Dhani N, Hedley DW (2010) Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opin Ther Targets 14:77-94
27. Shibue T, Weinberg RA (2009) Integrin beta1-focal adhesion kinase signalin2010 g directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106:10290-10295
28. Sieg DJ, Hauck CR, Ilic D et al (2000) FAKintegrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2:249-256
29. Slack-Davis JK, Martin KH, Tilghman RW et al (2007) Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 282:14845-14852
30. Steeg PS, Theodorescu D (2008) Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5:206-219
31. Tomar A, Schlaepfer DD (2010) A PAK-activated linker for EGFR and FAK. Dev Cell 18:170-172
32. Walsh C, Tanjoni I, Uryu S et al (2010) Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer Biol Ther 9:778-790
33. Webb DJ, Donais K, Whitmore LA et al (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6:154-161
34. Zheng D, Golubovskaya V, Kurenova E et al (2010) A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts. Mol Carcinog 49:200-209